Random Noise Stimulation to Enhance Cortical Drive & Improve Hand Function

Sponsor
Shepherd Center, Atlanta GA (Other)
Overall Status
Recruiting
CT.gov ID
NCT04777149
Collaborator
The Craig H. Neilsen Foundation (Other)
28
1
2
16
1.8

Study Details

Study Description

Brief Summary

Cervical spinal cord injury (SCI) results in hand and arm function impairments and decreased independence in performance of daily activities such as bathing, eating, dressing, writing, or typing. Recent approaches that involve the application of non-invasive brain stimulation have the potential to strengthen the remaining connections between the brain and the spinal cord for improved hand function. Combining brain stimulation with performing upper limb functional tasks may further increase the ability of individuals with tetraplegia to use their hands. The purpose of this study is to investigate if "random noise", a special type of brain stimulation that most people cannot feel, can be used to enhance upper limb function in individuals with spinal cord injury. Specifically, the investigators will examine if a combined treatment protocol of random noise and fine motor training results in greater improvements in motor and sensory hand function compared to fine motor training alone.

Condition or Disease Intervention/Treatment Phase
  • Other: transcranial Random Noise Stimulation (tRNS)
  • Other: transcranial Direct Current Stimulation (tDCS)
  • Other: sham-stimulation
N/A

Detailed Description

Cervical spinal cord injury (SCI) results in upper extremity (UE) functional impairments that can restrict independence, social participation, and overall quality of life. Evidence shows that short duration of non-invasive brain stimulation (NIBS) can strengthen the transmission of information through the spared corticospinal pathways and improve UE functional recovery in individuals with tetraplegia. Transcranial direct current stimulation (tDCS), which is a clinically accessible NIBS approach, has been used to modulate cortical plasticity and improve hand function. However, the high variability in the reported effects of tDCS raises questions about its clinical value and highlights the need to investigate more robust NIBS protocols. Transcranial random noise stimulation (tRNS) is a novel NIBS approach that produces more consistent facilitatory effects compared to tDCS. TRNS delivers a low alternating current with a continuously changing intensity over a wide frequency range. Further, tRNS has excellent tolerability and no risk of skin burns since it is a polarity independent stimulation approach. When tRNS is applied over the motor cortex, it increases cortical excitability in the hand representation area and enhances motor learning in healthy adults. Despite the potential promise of tRNS in increasing corticomotor drive for improved motor performance, its application in persons with SCI is novel. Therefore, in this study, the investigators propose to use tRNS to augment the therapeutic effects of functional task practice (FTP). Our aim is to compare the efficacy of a 3-day tRNS+FTP protocol on cortical excitability, UE motor, and sensory function to tDCS+FTP and to sham-stimulation+FTP in individuals with tetraplegia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Wash-in control designWash-in control design
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Random Noise Stimulation to Enhance Corticomotor Drive for Improved Hand Function
Anticipated Study Start Date :
Mar 1, 2021
Anticipated Primary Completion Date :
Jul 1, 2022
Anticipated Study Completion Date :
Jul 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: transcranial Random Noise Stimulation (tRNS)

Participants in this group will receive a combined intervention (3 days of tRNS during functional task practice and 3 days of sham-stimulation during functional task practice).

Other: transcranial Random Noise Stimulation (tRNS)
Two electrodes will be placed over the targeted areas on participant's head. A current of random frequency and intensity will be delivered. TRNS will be applied during the first 20 min of functional task practice.

Other: sham-stimulation
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered for 1- 2 min.

Active Comparator: transcranial Direct Current Stimulation (tDCS)

Participants in this group will receive a combined intervention (3 days of tDCS during functional task practice and 3 days of sham-stimulation during functional task practice).

Other: transcranial Direct Current Stimulation (tDCS)
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered. TDCS will be applied during the first 20 min of functional task practice.

Other: sham-stimulation
Two electrodes will be placed over the targeted areas on participant's head. A continuous low intensity current will be delivered for 1- 2 min.

Outcome Measures

Primary Outcome Measures

  1. Change in Cortical excitability [Baseline; Post Testing Week 1; Post Testing Week 2]

    The communication between brain and spinal cord will be evaluated. Sensors that detect muscle activity will be placed over hand muscles. Pulses of stimulation will be applied to the head using a type of non-invasive brain stimulation called transcranial magnetic stimulation (TMS). The size of the muscle response will be recorded.

  2. Change in Strength (key pinch and grasp strength) [Baseline; Post Testing Week 1; Post Testing Week 2]

    Key pinch and grasp strength will be assessed using a dynamometer.

  3. Change in Sensory function (sensation subtest of the Graded Redefined Assessment of Strength Sensibility and Prehension) [Baseline; Post Testing Week 1; Post Testing Week 2]

    Semmes and Weinstein Monofilaments will be applied on 3 dorsal and palmar sensory test locations in each hand. Each location is scored from 0 to 4.

Secondary Outcome Measures

  1. Change in Unimanual function (Grasp and Release Test) [Baseline; Post Testing Week 1; Post Testing Week 2]

    Participants will be required to grasp, move, and release six objects of different size and weight. For each task, the number of successful and unsuccessful attempts is 30s will be recorded.

  2. Change in Bimanual function (Chedoke Arm and Hand Activity Inventory) [Baseline; Post Testing Week 1; Post Testing Week 2]

    This test consists of 9 functional tasks that require bimanual coordination. Each item is graded on a 7-point activity scale with higher scores suggesting better bimanual function.

  3. Change in Sensory Function (revised Nottingham Sensory Assessment) [Baseline; Post Testing Week 1; Post Testing Week 2]

    Tactile sensation, proprioception, stereognosis, and two-point discrimination will be tested. Higher scores indicate better sensory function.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Spinal Cord Injury level above C8

  • ASIA Impairment Scale (AIS) classification level: C, D

  • Time since injury: ≥ 1 year

  • Active intrinsic hand muscles in at least one UE

  • Active extrinsic hand muscles in both UE

  • Ability to follow multiple step commands

  • Ability to communicate pain or discomfort

  • Willingness to participate in testing

  • Ability to obtain informed consent

Exclusion Criteria:
  • Implanted metallic device in the head and/ or pacemaker

  • History of seizures

  • History of severe headaches

  • Severe contractures of UE that would limit participation in FTP

  • Prior tendon or nerve transfer surgery

  • Received Botulinum toxin injection in the tested UE in the last 3 months

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shepherd Center Atlanta Georgia United States 30309

Sponsors and Collaborators

  • Shepherd Center, Atlanta GA
  • The Craig H. Neilsen Foundation

Investigators

  • Principal Investigator: Anastasia Zarkou, PT,MS,PhD, Shepherd Center, Atlanta GA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shepherd Center, Atlanta GA
ClinicalTrials.gov Identifier:
NCT04777149
Other Study ID Numbers:
  • 762
First Posted:
Mar 2, 2021
Last Update Posted:
Mar 3, 2021
Last Verified:
Mar 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Shepherd Center, Atlanta GA
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 3, 2021